Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2

In the past decade, we have observed exciting advances in lung cancer therapy, including the development of targeted therapies. However, additional strategies for early detection and tumor-based therapy are still essential in improving patient outcomes. EGF receptor (EGFR) and MET (the receptor tyro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Acunzo, Mario, Romano, Giulia, Palmieri, Dario, Laganá, Alessandro, Garofalo, Michela, Balatti, Veronica, Drusco, Alessandra, Chiariello, Mario, Nana-Sinkam, Patrick, Croce, Carlo M.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2013
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3666747/
https://ncbi.nlm.nih.gov/pubmed/23650389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1302107110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars